Read more about our research in the journal Clinical Gastroenterology and Hepatology: https://bit.ly/4eA8qIP #BMS_Employee | 11 comments on LinkedIn #bms_employee | Daniel Quirk, MD, MPH, MBA | 11 ...

The Minnesota Vikings did not sign Daniel Jones midway through the 2024 season for him to ride the bench behind Sam Darnold; they saw the move as a de facto job shadow for the 2025 season.

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. The latest readout positions Breyanzi for a ...

Bristol Myers Squibb said it has received positive results for its latest lymphoma treatment trials, the fifth type of cancer the drug has been shown to treat. The biopharmaceutical company said ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and broad Medicaid/Medicare coverage, supporting its blockbuster potential in schizophrenia and future label expansions.

Bristol Myers Squibb will cut $2 billion in costs by the end of 2027, a move aimed at long-term growth as the company prepares for patent expirations on key treatments, CNBC reported Feb. 6.

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks that Jim Cramer discussed 6 months ago during his show on July 29 ...

Stephanie Quirk joined the FOX6 News team in April 2023, and is proud to call Milwaukee her new home! Although she was raised in the Chicago suburbs, Stephanie has always considered herself a ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...

Before they were romantically involved, Charli XCX and The 1975’s George Daniel discovered they were great musical collaborators—and they’re still working together as she continues her Brat era.

Bristol-Myers Squibb has become the latest drugmaker in the US to file a legal challenge to a block on a drug rebate model opposed by a Health and Human Services (HHS) department. Specifically ...